Effect of COVID-19 inactivated vaccine on peripheral blood anti-β2-GPI antibody and outcomes in vitro fertilization-embryo transplantation

Int Immunopharmacol. 2023 Sep:122:110596. doi: 10.1016/j.intimp.2023.110596. Epub 2023 Jul 11.

Abstract

Corona Virus Disease 2019 (COVID-19) is an acute respiratory infection and a global public health event. The level of aβ2GPI is significantly up-regulated in COVID-19 patients. The impact of inactivated vaccination against COVID-19 on aβ2GPI and in vitro fertilization and embryo transfer (IVF-ET) remains unknown amidst the universal administration of COVID-19 vaccines. We conducted a retrospective study to assess the impact of COVID-19 inactivated vaccination on aβ2GPI levels and its effect on superovulation and pregnancy outcomes. We found aβ2GPI level is significantly up-regulated after vaccination. There was no statistical difference in mature egg rate, 2PN fertilization rate, day 3 high-quality embryo rate, blastocyst formation rate, embryo implantation rate and miscarriage rate between the vaccine group and control group. Our findings showed vaccination with COVID-19 inactivated vaccine can elevate the level of aβ2GPI in peripheral blood but have no effect on the outcomes of controlled ovarian hyperstimulation and pregnancy in IVF-ET.

Keywords: Anti-β(2) glycoprotein I antibody; COVID-19; COVID-19 inactivated vaccine; Controlled ovarian hyperstimulation; In vitro fertilization-embryo transfer.

MeSH terms

  • COVID-19 Vaccines*
  • COVID-19* / prevention & control
  • Embryo Transfer
  • Female
  • Fertilization in Vitro
  • Humans
  • Pregnancy
  • Retrospective Studies
  • Vaccines, Inactivated
  • beta 2-Glycoprotein I

Substances

  • COVID-19 Vaccines
  • beta 2-Glycoprotein I
  • Vaccines, Inactivated